In clinically, estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor type 2 receptor (HER2) are established biomarkers for breast cancer diagnosis, cancer subtypes analysis and specific treatment guidance. This evidence concerns the gene ERBB2 and breast cancer.